Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Claritev CorpCTEV · Entity 5238 | SVP, Chief Growth Officer | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Claritev Corp
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 123,723 |
Reported balance
After 2026-08-14 transaction · row 1
1 source rowRow 1 · 2026-08-14 · Sale · Disposed 8,850 · Balance 123,723 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $41.72, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $41.72, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 21:07 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A common stock | 8,850 | $40.07 | $354,592.95 |
DisclosureSEC source: 0002041258-26-000004 · wk-form4_1787087222.xml · nonDerivative · entry 1 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,723 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $41.72, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:01 UTC | Claritev Corp CTEV · Entity 5238 | Disposition to issuerCash Settled Restricted Stock Units · Derivative | 10,123 | $0.00 | $0.00 |
DisclosureSEC source: 0002041258-26-000002 · wk-form4_1772578866.xml · derivative · entry 3 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,124 Underlying: Class A common stock · 10,123 shares Expires not disclosed F3 · derivative.exercise_price: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. F3 · derivative.exercise_date: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. F3 · derivative.expiration_date: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:01 UTC | Claritev Corp CTEV · Entity 5238 | GrantClass A common stock | 26,342 | $0.00 | $0.00 |
DisclosureSEC source: 0002041258-26-000002 · wk-form4_1772578866.xml · nonDerivative · entry 2 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,573 F2 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2027, 2028, 2029, and 2030. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:01 UTC | Claritev Corp CTEV · Entity 5238 | Tax withholdingClass A common stock | 1,660 | $13.47 | $22,360.20 |
DisclosureSEC source: 0002041258-26-000002 · wk-form4_1772578866.xml · nonDerivative · entry 1 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,231 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2025. Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:14 UTC | Claritev Corp CTEV · Entity 5238 | Tax withholdingClass A common stock, par value $0.0001 per share | 7,684 | $55.26 | $424,617.84 |
DisclosureSEC source: 0002041258-25-000004 · wk-form4_1760645642.xml · nonDerivative · entry 1 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,891 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:22 UTC | Claritev Corp CTEV · Entity 5238 | GrantCash Settled Restricted Stock Units · Derivative | 20,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-25-000040 · wk-form4_1741141322.xml · derivative · entry 2 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,247 Underlying: Class A common stock · 20,247 shares Expires not disclosed F2 · derivative.exercise_price: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV)per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. F2 · derivative.exercise_date: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV)per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. F2 · derivative.expiration_date: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV)per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:22 UTC | Claritev Corp CTEV · Entity 5238 | GrantClass A common stock, par value $0.0001 per share | 20,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-25-000040 · wk-form4_1741141322.xml · nonDerivative · entry 1 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,575 F1 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2026, 2027, 2028, and 2029. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:01 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock, par value $0.0001 per share | 95,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-24-000141 · wk-form4_1729112454.xml · nonDerivative · entry 1 Misencik Tiffani · CIK 0002041258 · SVP, Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,328 F1 · kind: Represents a grant of time-based restricted stock units which shall vest at a rate of 25% per year on each of October 14, 2025, 2026, 2027, and 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.